Impel Pharmaceuticals (NASDAQ:IMPL) reported its Q1 earnings results on Friday, May 12, 2023 at 08:00 AM.

Here's what investors need to know about the announcement.

Earnings

Impel Pharmaceuticals missed estimated earnings by 41.11%, reporting an EPS of $-1.27 versus an estimate of $-0.9.

Revenue was up $2.61 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.14 which was followed by a 3.82% increase in the share price the next day.

Here's a look at Impel Pharmaceuticals's past performance:

To track all earnings releases for Impel Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.